Population differences in breast cancer: Survey in indigenous african women reveals over-representation of triple-negative breast cancer

Journal of Clinical Oncology

Volumn 27, Issue 27, 2009, Pages 4515-4521

  Huo, Dezheng ^a   Ikpatt, Francis ^a   Khramtsov, Andrey ^a   Dangou, Jean Marie ^a   Nanda, Rita ^a   Dignam, James ^a   Zhang, Bifeng ^a   Grushko, Tatyana ^a   Zhang, Chunling ^a   Oluwasola, Olayiwola ^a   Malaka, David ^a   Malami, Sani ^a   Odetunde, Abayomi ^a   Adeoye, Adewumi O ^a   Iyare, Festus ^a   Falusi, Adeyinka ^a   Perou, Charles M ^a   Olopade, Olufunmilayo I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA PROTEIN 2; CYCLIN D1; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AFRICA; ARTICLE; BREAST CANCER; CANCER INVASION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TISSUE MICROARRAY;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENES, ERBB-2; HEALTH SURVEYS; HUMANS; MIDDLE AGED; NIGERIA; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENEGAL; TUMOR MARKERS, BIOLOGICAL;

EID: 71049148231     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.6873     Document Type: Article

References (29)

1. Smigal C, Jemal A, Ward E, et al: Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin 56:168-183, 2006
2. Eley JW, Hill HA, Chen VW, et al: Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947-954, 1994
3. Smith-Bindman R, Miglioretti DL, Lurie N, et al: Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144:541-553, 2006
4. Newman LA, Griffith KA, Jatoi I, et al: Metaanalysis of survival in African American and white American patients with breast cancer: Ethnicity compared with socioeconomic status. J Clin Oncol 24:1342-1349, 2006
5. Chlebowski RT, Chen Z, Anderson GL, et al: Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439-448, 2005
6. Chu KC, Anderson WF: Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 74:199-211, 2002
7. Bowen RL, Duffy SW, Ryan DA, et al: Early onset of breast cancer in a group of British black women. Br J Cancer 98:277-281, 2008
8. Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000
9. Fan C, Oh DS, Wessels L, et al: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560-569, 2006
10. Nielsen TO, Hsu FD, Jensen K, et al: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367-5374, 2004
11. Carey LA, Perou CM, Livasy CA, et al: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502, 2006
12. Bauer KR, Brown M, Cress RD, et al: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triplenegative phenotype: A population-based study from the California cancer Registry. Cancer 109:1721-1728, 2007
13. Ihemelandu CU, Leffall LD Jr, Dewitty RL, et al: Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: Age-specific prevalence and survival. J Surg Res 143:109-118, 2007
14. Yang XR, Sherman ME, Rimm DL, et al: Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16:439-443, 2007
15. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150, 2006
16. Adebamowo CA, Adekunle OO: Casecontrolled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg 86:665-668, 1999
17. Ihekwaba FN: Breast cancer in Nigerian women. Br J Surg 79:771-775, 1992
18. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer-Experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
19. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
20. Reiner A, Neumeister B, Spona J, et al: Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50:7057-7061, 1990
21. Eisen MB, Spellman PT, Brown PO, et al: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863-14868, 1998
22. Gukas ID, Jennings BA, Mandong BM, et al: Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 24:209-213, 2005
23. Ikpatt OF, Ndoma-Egba R: Oestrogen and progesterone receptors in Nigerian breast cancer: Relationship to tumour histopathology and survival of patients. Cent Afr J Med 49:122-126, 2003
24. Adebamowo CA, Famooto A, Ogundiran TO, et al: Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110:183-188, 2008
25. Ries L, Melbert D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2005. Bethesda, MD, National Cancer Institute, 2008
26. Kurebayashi J, Moriya T, Ishida T, et al: The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast 16:S72-S77, 2007 (suppl 2)
27. Millikan RC, Newman B, Tse CK, et al: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123-139, 2008
28. Rakha EA, El-Sayed ME, Green AR, et al: Prognostic markers in triple-negative breast cancer. Cancer 109:25-32, 2007
29. Livasy CA, Karaca G, Nanda R, et al: Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19:264-271, 2006